GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SeouLinBioscience Co Ltd (XKRX:038070) » Definitions » EV-to-Revenue

SeouLinBioscience Co (XKRX:038070) EV-to-Revenue : 0.51 (As of May. 28, 2024)


View and export this data going back to 2005. Start your Free Trial

What is SeouLinBioscience Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, SeouLinBioscience Co's enterprise value is ₩44,127 Mil. SeouLinBioscience Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₩85,821 Mil. Therefore, SeouLinBioscience Co's EV-to-Revenue for today is 0.51.

The historical rank and industry rank for SeouLinBioscience Co's EV-to-Revenue or its related term are showing as below:

XKRX:038070' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.36   Med: 1.27   Max: 3.86
Current: 0.51

During the past 13 years, the highest EV-to-Revenue of SeouLinBioscience Co was 3.86. The lowest was 0.36. And the median was 1.27.

XKRX:038070's EV-to-Revenue is ranked better than
90.17% of 1038 companies
in the Biotechnology industry
Industry Median: 8.145 vs XKRX:038070: 0.51

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-28), SeouLinBioscience Co's stock price is ₩8550.00. SeouLinBioscience Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₩10,282.83. Therefore, SeouLinBioscience Co's PS Ratio for today is 0.83.


SeouLinBioscience Co EV-to-Revenue Historical Data

The historical data trend for SeouLinBioscience Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SeouLinBioscience Co EV-to-Revenue Chart

SeouLinBioscience Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.80 1.32 1.40 0.59 0.56

SeouLinBioscience Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.59 0.75 0.53 0.56 0.66

Competitive Comparison of SeouLinBioscience Co's EV-to-Revenue

For the Biotechnology subindustry, SeouLinBioscience Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SeouLinBioscience Co's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SeouLinBioscience Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where SeouLinBioscience Co's EV-to-Revenue falls into.



SeouLinBioscience Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

SeouLinBioscience Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=44126.696/85820.816
=0.51

SeouLinBioscience Co's current Enterprise Value is ₩44,127 Mil.
SeouLinBioscience Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩85,821 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SeouLinBioscience Co  (XKRX:038070) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

SeouLinBioscience Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=8550.00/10282.826
=0.83

SeouLinBioscience Co's share price for today is ₩8550.00.
SeouLinBioscience Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩10,282.83.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SeouLinBioscience Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of SeouLinBioscience Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


SeouLinBioscience Co (XKRX:038070) Business Description

Traded in Other Exchanges
N/A
Address
4F, A-dong, Korea Bio Park, 694-1, Sampyeong-dong, Bundang-gu, Seongnam-si, Gyeonggi-do, KOR, 463-400
SeouLinBioscience Co Ltd is a South Korean company operating in biotechnology industry. The company focuses on bio research and production, manufacturing, diagnostics, and healthcare.

SeouLinBioscience Co (XKRX:038070) Headlines

No Headlines